Diego Pizzagalli Related Content

Neurotherapeutics Offer Hope for Treatment-Resistant Depression

As a young psychiatrist, Stephen J. Seiner, MD, witnessed how effective electroconvulsive therapy (ECT) was for some of the depressed patients he encountered during a geriatric fellowship at McLean. “I saw how lifesaving it could be for patients who did not respond to medication,” said Seiner. After...

McLean Hospital and GrayMatters Health Awarded a BIRD Foundation Grant

GrayMatters Health, a digital therapeutics start-up company, announced that the BIRD Israel-U.S. Binational Industrial Research and Development Foundation awarded a grant to McLean Hospital and the company to develop a novel solution for the therapy of major depressive disorder (MDD) with anhedonia...

Philanthropy Bolsters Research Into Teen Depression

How do you predict which teenagers will develop clinical depression? Can you use brain activity, mood or behavior patterns, and other information? Are there targeted prevention strategies that could stop a vulnerable young person from plunging into depression? And for teenagers who are currently...

Pizzagalli Receives 2017 Joel Elkes Research Award

On December 4, 2017, the American College of Neuropsychopharmacology (ACNP) honored McLean Hospital’s Diego A. Pizzagalli, PhD, with the 2017 Joel Elkes Research Award. The ACNP presents this annual award in recognition of a scientist’s outstanding clinical contribution to neuropsychopharmacology...

Understanding the Biology Behind Major Depressive Disorder

Major depressive disorder (MDD) affects about 7% of people in the United States each year. Although researchers and clinicians know that stressful life events can trigger a depressive episode, the biological mechanisms behind it are not well understood. Studies led by Diego A. Pizzagalli, PhD...

Manton Foundation Funds State of the Art MRI Scanner

Scott E. Lukas, PhD, director of the McLean Imaging Center (MIC), can barely contain his excitement when describing McLean’s new 3 Tesla Siemens PRISMA MRI scanner. An extraordinary $3.75M grant from the Manton Foundation funded this state of the art acquisition. According to Lukas and fellow MIC...

The O’Keefe Awards: Catalyzing Research, Jump-Starting Careers

One researcher is looking at how administering xenon gas may minimize injury to a traumatized brain. Another is studying how childhood sexual abuse affects brain function and increases the risk of re-victimization. A third is trying to understand the connection between early tobacco use and later...

McLean Launches Center for Depression, Anxiety and Stress Research

Depression, anxiety, and stress are a debilitating triad. About one in six Americans will suffer from depression at some point in his or her life; one in four will struggle with an anxiety disorder. Often, the two go hand in hand, triggered by stressors like childhood neglect or the death of a loved...